Prescription drug · NDA
Thyquidity (Levothyroxine sodium) NDC 82685-360
Levothyroxine sodium 100 ug/5mL · Solution · Oral · Oliva Therapeutics, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82685-360-01 | 8268503600182685036001 | 1 BOTTLE, GLASS in 1 CARTON (82685-360-01) / 100 mL in 1 BOTTLE, GLASSMarketed from Jul 1, 2025 | |
| 82685-360-02 | 8268503600282685036002 | 2 BOTTLE, GLASS in 1 CARTON (82685-360-02) / 100 mL in 1 BOTTLE, GLASSMarketed from Jul 1, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Thyquidity
- Generic name (nonproprietary)
- levothyroxine sodium
- Active ingredients
- Levothyroxine sodium — 100 ug/5mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Oliva Therapeutics, LLCNDC labeler code 82685
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 214047
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)
- Identifiers
- Product ID 82685-360_390a4d8d-b481-0d9a-e063-6394a90a9b53SPL ID 390a4d8d-b481-0d9a-e063-6394a90a9b53SPL set ID 0c839877-50e4-455f-9b6c-462efb09cb96RxCUI 2473276, 2473282UNII 9J765S329GUPC 0382685360014
- Pharmacologic class
- l-Thyroxine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482685036001followed by a unit qualifier and the quantityPackage 82685-0360-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Hypothyroidism THYQUIDITY is indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression THYQUIDITY is indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use: THYQUIDITY is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with THYQUIDITY may induce hyperthyroidism [see Warnings and Precautions (5.4) ]. THYQUIDITY is not i…
Excerpt only. Read the full label for complete information.
About NDC 82685-360
- What is NDC 82685-360?
- 82685-360 is the product NDC for Thyquidity (levothyroxine sodium), Levothyroxine sodium 100 ug/5mL solution, listed with the FDA by Oliva Therapeutics, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Thyquidity (Levothyroxine Sodium).
- What is the active ingredient?
- Levothyroxine sodium.
- Who is the labeler?
- Oliva Therapeutics, LLC, NDC labeler code 82685. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Thyquidity?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.